HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Use of laser capture microdissection and surface-enhanced laser desorption ionization time-of-flight mass spectrometry to screen differential proteins in lung adenocarcinoma and lung squamous carcinoma].

AbstractOBJECTIVE:
To screen biomarkers for classification in lung adenocarcinoma and lung squamous carcinoma by using laser capture microdissection (LCM) and surface-enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS) and support vector machine (SVM).
METHODS:
Six specimens of lung adenocarcinoma tissues and seven specimens of lung squamous carcinoma tissues obtained during operation were made into frozen sections and stained by improved H-E solution. About 1.2 x 10(5) of homogeneous adenocarcinoma cells and 1.4 x 10(5) of homogeneous lung squamous carcinoma cells were collected using LCM. Then SELDI profiles based on PBS II(+)SELDI-TOF-MS (IMAC protein chip) and the data were analyzed by support vector machine (SVM).
RESULTS:
Eighty seven differential protein peaks were found and top ten of them were identified as candidate biomarkers. The expression levels of 6 proteins among them with the molecular weights of 3333, 3592, 3848, 5036, 5191, and 5211 respectively in the lung squamous cancer tissues were weaker than those in the adenocarcinoma tissues, and the expression levels of 4 proteins with the molecular weights of 2505, 4004, 4847, and 11 412 in the lung squamous carcinoma tissues were stronger than those in the adenocarcinoma tissues. The expression of the protein with the molecular weight of 4847 in the squamous cancer was significantly stronger than that in the adenocarcinoma (p + 0.032). A discriminatory pattern consisting of 3 proteins with the molecular weights of 4847, 11 412, and 3592 was established with a sensitivity of 100% and a specificity of 100% respectively in separating adenocarcinoma from squamous carcinoma.
CONCLUSION:
There is a difference in protein component between adenocarcinoma and squamous carcinoma. LCM combined with SELDI-TOF-MS help screen a biomarker pattern to distinguish lung adenocarcinoma from lung squamous carcinoma with high sensitivity and specificity.
AuthorsYing-Xuan Tian, Shuan-Ying Yang, Yan-Dong Nan, Wei Zhang, Bin Zhou, Li-Na Bu, Shu-Fen Huo, Jie-Kai Yu, Shu Zheng
JournalZhonghua yi xue za zhi (Zhonghua Yi Xue Za Zhi) Vol. 88 Issue 3 Pg. 145-8 (Jan 15 2008) ISSN: 0376-2491 [Print] China
PMID18361807 (Publication Type: English Abstract, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Proteome
Topics
  • Adenocarcinoma (metabolism, pathology)
  • Aged
  • Carcinoma, Squamous Cell (metabolism, pathology)
  • Female
  • Humans
  • Lung Neoplasms (metabolism, pathology)
  • Male
  • Mass Spectrometry (methods)
  • Middle Aged
  • Molecular Weight
  • Neoplasm Staging
  • Proteome (analysis, chemistry)
  • Proteomics (methods)
  • Reproducibility of Results
  • Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: